Skip to content

Clinical trials

Phase 2 Fallopian Tube Neoplasms trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Fallopian Tube Neoplasms Phase: Phase 2 Country / region: Canada Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20022
20032
20041
20063
20071
20091
20102
20111
20131
20141
20161
20181
20191
20211
20221
20232
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Active, not recruiting4
Recruiting3
Unknown status3
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)8
University Health Network, Toronto5
AltaRex2
NCIC Clinical Trials Group2
AbbVie1
Canadian Cancer Trials Group1
Corcept Therapeutics1
Fore Biotherapeutics1
GlaxoSmithKline1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Fallopian Tube Neoplasms28
Ovarian Neoplasms23
Carcinoma, Ovarian Epithelial12
Neoplasms4
Breast Neoplasms2
Carcinoma, Hepatocellular2
Peritoneal Neoplasms2
Biliary Tract Neoplasms1
Brenner Tumor1
Carcinoma1

Trials

Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.